- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about Teva
Recent news which mentions Teva
Teva Pharmaceutical Lifts Revenue Forecast - Huntington's And Migraine Drugs Help Q3 Performance
November 08, 2023
Tickers
TEVA
From Benzinga
Teva shares climb as third-quarter sales top estimates
November 08, 2023
From MarketWatch
US Stocks Set To Open Flat After Hot 7-Day Rally: Traders Sharpen Focus On Powell's Speech, Disney Earnings
November 08, 2023
From Benzinga
Earnings Scheduled For November 8, 2023
November 08, 2023
From Benzinga
Alkermes Q3 Earnings Top Consensus, On Track To Separate Oncology Business, Reaffirms FY23 Outlook
October 25, 2023
From Benzinga
From Benzinga
Israel Could Form Emergency Government: Defense Stocks, Israel ETFs In Focus During Conflict
October 10, 2023
From Benzinga
Israeli Stocks Fall as Investors Fear Middle East Conflict
October 09, 2023
Tags
MBLY
Today's Market
NASDAQ:MBLY,NASDAQ:MNDY,NYSE:FVRR,NYSE:TEVA,NASDAQ:HUBC,NASDAQ:TATT,NASDAQ:ESLT
From InvestorPlace
Cathie Wood's ARK Israel Innovative Tech ETF Braces For Impact Amid Regional Warfare: 10 Stocks To Watch
October 09, 2023
From Benzinga
From MarketWatch
Stock market is oversold — but investors don’t believe it yet
October 05, 2023
From MarketWatch
From Benzinga
Teva partnership with Sanofi ‘will pay dividends,’ analyst says
October 04, 2023
From MarketWatch
Sanofi, Teva Pledge $1.5B To Target Inflammatory Bowel Disease That Impacts Almost 10M People
October 04, 2023
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 02, 2023
From Benzinga
Stocks are stuck in the breakdown lane and repairs will take time
September 28, 2023
From MarketWatch
Apple Defends Its $19B Google Search Deal, Hollywood's Writers Secure Credit For AI Training, China's Ambitious Chip Fund Faces Headwinds: Today's Top Stories
September 27, 2023
From Benzinga
Migraine Medication Battle: Eli Lilly Prevails in Patent Infringement Case Against Teva
September 27, 2023
From Benzinga
Despite Efforts, Vulnerable Patients Still Face Barriers to Essential Medicines, Says New Report
September 26, 2023
From Benzinga
The bullish case for U.S. stocks is getting weaker
September 21, 2023
From MarketWatch
Stocks are trapped in a trading range. Something’s got to give.
September 14, 2023
From MarketWatch
3 No-Brainer Stocks to Buy With $20 Right Now
September 13, 2023
From Motley Fool
Why Can't You Find Adderall? Inside the Ongoing Shortage of ADHD Medication In US
September 12, 2023
Tickers
TEVA
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 11, 2023
From Benzinga
How A Small Indian Firm Firm Was Pulled Into A Legal Battle with Big Pharma Over A Cancer Drug
September 11, 2023
From Benzinga
Bristol Myers' Antitrust Allegations: Lawsuit Over Alleged Patent Deception For Blood Cancer Drug
September 07, 2023
From Benzinga
From Benzinga
Big Pharma Price-Fixing: Teva and Glenmark's $255M Settlement Shines Light on Industry Issues
August 22, 2023
Tickers
TEVA
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.